Name | Acevaltrate |
Synonyms | 25161-41-5 acevaltrate Acevaltrate Acevaltratum Acetovaltrate Acetoxyvaltrate (Acetyloxy)valepotriate (1S,6S,7R,7aS)-4-(Acetoxymethyl)-1-[(3-methylbutanoyl)oxy]-6,7a-dihydro-1H-spiro[cyclopenta[c]pyran-7,2'-oxiran]-6-yl 3-acetoxy-3-methylbutanoate (1S,6S,7R,7aS)-4-[(acetyloxy)methyl]-1-[(3-methylbutanoyl)oxy]-6,7a-dihydro-1H-spiro[cyclopenta[c]pyran-7,2'-oxiran]-6-yl 3-(acetyloxy)-3-methylbutanoate 1,7a-Dihydro-1,6-dihydroxyspiro(cyclopenta[c]pyran-7(6H),2'-oxirane)-4-methanol 4-Acetate 1(or 6)-Isovalerate 6(or 1)-(3-Hydroxy-3-methylbutyrate Acetate) 3-Acetyloxy-3-methylbutyric acid [(1S,7R)-4-(acetyloxy)methyl-6,7aα-dihydro-1α-(3-methyl-1-oxobutoxy)spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-6α-yl] ester 3-(Acetyloxy)-3-methylbutanoic acid (1S,2'R,6S,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydro-1-(3-methyl-1-oxobutoxy)spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-6-yl ester Butanoic acid,3-(acetyloxy)-3-methyl-,(1S,2'R,6S,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydro-1-(3-methyl-1-oxobutoxy)spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-6-ylester butanoic acid, 3-(acetyloxy)-3-methyl-, (1S,6S,7R,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydro-1-(3-methyl-1-oxobutoxy)spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-6-yl ester |
CAS | 25161-41-5 |
EINECS | 246-685-1 |
InChI | InChI=1/C24H32O10/c1-13(2)7-19(27)33-22-21-17(16(11-30-22)10-29-14(3)25)8-18(24(21)12-31-24)32-20(28)9-23(5,6)34-15(4)26/h8,11,13,18,21-22H,7,9-10,12H2,1-6H3/t18-,21+,22-,24+/m0/s1 |
Molecular Formula | C24H32O10 |
Molar Mass | 480.5 |
Density | 1.26 |
Melting Point | 80-81 °C |
Boling Point | 538.7±50.0 °C(Predicted) |
Specific Rotation(α) | +163.7 (MeOH) |
Flash Point | 229°C |
Solubility | DMSO : ≥ 125 mg/mL (260.15 mM) |
Vapor Presure | 1.13E-11mmHg at 25°C |
Appearance | Powder |
Storage Condition | 2-8°C |
Refractive Index | 1.53 |
In vitro study | Acevaltrate differentiallys inhibit the activity of rat P-type ATPases in vitro. 60.7±7.3% inhibition of the rat H + /K + -ATPase is achieved at 100 µM. |